M. Berman

A high‐throughput capillary isoelectric focusing immunoassay for fingerprinting protein sialylation

Young Jun Choi, S. Estes, T. Ryll, 2016, Biotechnology progress.

A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.

M. Subramanyam, T. Plavina, B. Schlain, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Immune Response After One Dose of Intramuscular Vaccination With the BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 Vaccine in Healthcare Workers: The Effect of Age and Vitamin D

W. Fraser, E. English, I. Piec, 2021, SSRN Electronic Journal.

Longitudinal Stability of Anti-JC Virus Antibody Status in Multiple Sclerosis Patients: Results of STRATIFY-1 (S30.001)

M. Subramanyam, T. Plavina, G. Bloomgren, 2013 .

Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma.

K. Simon, L. Gorelik, M. Subramanyam, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease

K. Luk, A. Cole-Strauss, C. Bennett, 2021, JCI insight.

Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery

M. Amiji, G. Mattheolabakis, M. Berman, 2016, Expert opinion on drug delivery.

Anti‐JC virus antibodies: Implications for PML Risk Stratification

K. Simon, A. Sandrock, S. Bixler, 2010, Annals of neurology.

Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease

K. Luk, A. Cole-Strauss, C. Bennett, 2019, bioRxiv.

Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.

M. Subramanyam, M. Berman, J. Goyal, 2015, Bioanalysis.

An enhanced ELISA for detection of anti-JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification

M. Subramanyam, T. Plavina, B. Schlain, 2012 .

Anti‐JC virus antibodies: Implications for PML Risk Stratification

K. Simon, A. Sandrock, S. Bixler, 2010, Annals of neurology.